107 related articles for article (PubMed ID: 1620555)
1. Detection of phosphorylated retTPC oncogene product in cytoplasm.
Ishizaka Y; Shima H; Sugimura T; Nagao M
Oncogene; 1992 Jul; 7(7):1441-4. PubMed ID: 1620555
[TBL] [Abstract][Full Text] [Related]
2. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.
Lanzi C; Borrello MG; Bongarzone I; Migliazza A; Fusco A; Grieco M; Santoro M; Gambetta RA; Zunino F; Della Porta G
Oncogene; 1992 Nov; 7(11):2189-94. PubMed ID: 1437145
[TBL] [Abstract][Full Text] [Related]
3. A high phosphorylation state and increased activity of the TRE motif in the NIH3T3 cell transformant induced by retTPC.
Ishizaka Y; Takahashi M; Ushijima T; Sugimura T; Nagao M
Biochem Biophys Res Commun; 1991 Sep; 179(3):1331-6. PubMed ID: 1930177
[TBL] [Abstract][Full Text] [Related]
4. Detection of RET oncogene activation in human papillary thyroid carcinomas by in situ hybridisation.
Fabien N; Paulin C; Santoro M; Berger N; Grieco M; Galvain D; Barbier Y; Dubois PM; Fusco A
Br J Cancer; 1992 Dec; 66(6):1094-8. PubMed ID: 1457350
[TBL] [Abstract][Full Text] [Related]
5. Detection of retTPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method.
Ishizaka Y; Kobayashi S; Ushijima T; Hirohashi S; Sugimura T; Nagao M
Oncogene; 1991 Sep; 6(9):1667-72. PubMed ID: 1717926
[TBL] [Abstract][Full Text] [Related]
6. RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho.
Barone MV; Sepe L; Melillo RM; Mineo A; Santelli G; Monaco C; Castellone MD; Tramontano D; Fusco A; Santoro M
Oncogene; 2001 Oct; 20(48):6973-82. PubMed ID: 11704822
[TBL] [Abstract][Full Text] [Related]
7. Detection of the PTC/retTPC oncogene in human thyroid cancers.
Jhiang SM; Caruso DR; Gilmore E; Ishizaka Y; Tahira T; Nagao M; Chiu IM; Mazzaferri EL
Oncogene; 1992 Jul; 7(7):1331-7. PubMed ID: 1620547
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.
Santoro M; Dathan NA; Berlingieri MT; Bongarzone I; Paulin C; Grieco M; Pierotti MA; Vecchio G; Fusco A
Oncogene; 1994 Feb; 9(2):509-16. PubMed ID: 8290261
[TBL] [Abstract][Full Text] [Related]
9. Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas.
Bongarzone I; Butti MG; Coronelli S; Borrello MG; Santoro M; Mondellini P; Pilotti S; Fusco A; Della Porta G; Pierotti MA
Cancer Res; 1994 Jun; 54(11):2979-85. PubMed ID: 8187085
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine kinase activity of the ret proto-oncogene products in vitro.
Miyazaki K; Asai N; Iwashita T; Taniguchi M; Isomura T; Funahashi H; Takagi H; Matsuyama M; Takahashi M
Biochem Biophys Res Commun; 1993 Jun; 193(2):565-70. PubMed ID: 7685595
[TBL] [Abstract][Full Text] [Related]
11. The ret oncogene products are membrane-bound glycoproteins phosphorylated on tyrosine residues in vivo.
Taniguchi M; Iwamoto T; Hamaguchi M; Matsuyama M; Takahashi M
Biochem Biophys Res Commun; 1991 Nov; 181(1):416-22. PubMed ID: 1958211
[TBL] [Abstract][Full Text] [Related]
12. cDNA cloning and characterization of ret activated in a human papillary thyroid carcinoma cell line.
Ishizaka Y; Ushijima T; Sugimura T; Nagao M
Biochem Biophys Res Commun; 1990 Apr; 168(2):402-8. PubMed ID: 2334411
[TBL] [Abstract][Full Text] [Related]
13. RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1.
Kim DW; Hwang JH; Suh JM; Kim H; Song JH; Hwang ES; Hwang IY; Park KC; Chung HK; Kim JM; Park J; Hemmings BA; Shong M
Mol Endocrinol; 2003 Jul; 17(7):1382-94. PubMed ID: 12738763
[TBL] [Abstract][Full Text] [Related]
14. Presence of aberrant transcripts of ret proto-oncogene in a human papillary thyroid carcinoma cell line.
Ishizaka Y; Itoh F; Tahira T; Ikeda I; Ogura T; Sugimura T; Nagao M
Jpn J Cancer Res; 1989 Dec; 80(12):1149-52. PubMed ID: 2516841
[TBL] [Abstract][Full Text] [Related]
15. Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET-fused gene RFG5.
Klugbauer S; Demidchik EP; Lengfelder E; Rabes HM
Cancer Res; 1998 Jan; 58(2):198-203. PubMed ID: 9443391
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of multiple isoforms of the ELKS mRNAs involved in a papillary thyroid carcinoma.
Nakata T; Yokota T; Emi M; Minami S
Genes Chromosomes Cancer; 2002 Sep; 35(1):30-7. PubMed ID: 12203787
[TBL] [Abstract][Full Text] [Related]
17. RET receptor expression in thyroid follicular epithelial cell-derived tumors.
Bunone G; Uggeri M; Mondellini P; Pierotti MA; Bongarzone I
Cancer Res; 2000 Jun; 60(11):2845-9. PubMed ID: 10850426
[TBL] [Abstract][Full Text] [Related]
18. Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.
Takahashi M; Buma Y; Iwamoto T; Inaguma Y; Ikeda H; Hiai H
Oncogene; 1988 Nov; 3(5):571-8. PubMed ID: 3078962
[TBL] [Abstract][Full Text] [Related]
19. Antitumor capacity of a dominant-negative RET proto-oncogene mutant in a medullary thyroid carcinoma model.
Drosten M; Stiewe T; Pützer BM
Hum Gene Ther; 2003 Jul; 14(10):971-82. PubMed ID: 12869215
[TBL] [Abstract][Full Text] [Related]
20. Identification of the ret proto-oncogene products in neuroblastoma and leukemia cells.
Takahashi M; Buma Y; Taniguchi M
Oncogene; 1991 Feb; 6(2):297-301. PubMed ID: 2000222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
